NO-MEDIATED MODIFICATION OF NMDA RECEPTOR DURING HYPOXIA
NO-MEDIATED MODIFICATION OF NMDA RECEPTOR DURING HYPOXIA
批准号:
7675059
负责人:
OM P MISHRA
金额:
$31.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-06-01 至 2010-08-31
关键词:
7-nitroindazoleActive SitesAddressAnimalsArginineBindingBiotinBrainCaspaseCell DeathCell membraneCerebral HypoxiaCerebral cortexCerebrumCessation of lifeCharacteristicsChargeCyclic AMP-Responsive DNA-Binding ProteinCysteineDNADNA FragmentationDNA NucleotidylexotransferaseDNTT geneDataDevelopmentDiethylaminesEnergy MetabolismEnzymesEpidermal Growth Factor ReceptorFluorescence SpectrometryFree RadicalsFunctional disorderGenerationsGenetic TranscriptionHypoxiaHypoxic Neuronal DeathImmunoblottingIn Situ Nick-End LabelingIn VitroLabelLeadMass Spectrum AnalysisMeasurementMediatingMembraneModelingModificationMolecularN-Methyl-D-Aspartate ReceptorsNeuronsNewborn InfantNitric OxideNitric Oxide DonorsNitric Oxide SynthaseNitric Oxide Synthase Type INuclearNumbersObject AttachmentPathway interactionsPeroxonitritePhosphocreatinePhosphorylationPhosphotransferasesPrevention strategyProtein DephosphorylationProtein Tyrosine KinaseProtein Tyrosine PhosphataseProteinsProtocols documentationSH protein-tyrosine phosphataseSodiumTechniquesTestingTissuesTyrosineTyrosine Phosphorylationapoptotic protease-activating factor 1basecalmodulin-dependent protein kinase IVcaspase-3caspase-9designdiethylamineenzyme activityindexinginhibitor/antagonistinorganic phosphatekinase inhibitornovelpro-caspase-3pro-caspase-9protein expressionprotein tyrosine phosphatase 1Bsrc-Family Kinases
中文摘要
拟议的研究将探讨一氧化氮(NO)介导的前天冬氨酸酶-9激活机制,
通过转录非依赖性和转录依赖性途径导致缺氧性神经元死亡
刚出生的。我们将检验这样一种假设,即缺氧时产生的NO会导致磷酸化增加
原天冬氨酸酶-9的酪氨酸153(Tyr153)和酪氨酸24(Tyr24)的磷酸化增加
蛋白水解酶激活因子-1(APAF-1)导致酪氨酸磷酸化激活
Proaspase-9..我们认为,低氧时特定残基的酪氨酸磷酸化导致
由于电荷相互作用增加,原天冬氨酸氨基转移酶-9与APAF-1的结合增加(增加
它们的原结构域之间的氢键数量),并导致原天冬氨酸氨基转移酶-9的激活增加。我们
提出低氧时产生的NO自由基可导致蛋白酪氨酸磷酸酶失活
(PTP,SH-PTP-1和SH-PTP-2),并导致蛋白酪氨酸激酶(PTK,EGFR)的激活增加
激酶和Src激酶),随后增加原天冬氨酸氨基转移酶-9和APAF-1的酪氨酸磷酸化。
脑组织缺氧的程度将通过测量高能磷酸盐来确定
化合物。实验方案将在新生仔猪上进行,调查:(1)
低氧对前天冬氨酸氨基转移酶-9的Tyr153磷酸化和APAF-1的Tyr24磷酸化的影响
原天冬氨酸氨基转移酶-9的激活及其与脑缺氧程度的关系;并进行这些研究
给予高度选择性的nNOS抑制剂以证明缺氧诱导的
前天冬氨酸氨基转移酶-9的Tyr153磷酸化,APAF-1的Tyr24磷酸化,表达和激活增加
原天冬氨酸氨基转移酶-9的表达是由nNOS产生的NO介导的;(2)EGFR激酶和Src抑制剂的作用
酪氨酸天冬氨酸氨基转移酶原-9在Tyr153处和APAF-1在Tyr24处的磷酸化增加,激活原天冬氨酸氨基转移酶-2
9和原天冬氨酸氨基转移酶-3、细胞核DNA片段化及免疫细胞化学和形态指标
神经元死亡,以证明导致缺氧的原天冬氨酸酶-9激活的机制
神经元的死亡依赖于EGFR和Src激酶的活性;(3)酪氨酸磷酸化和
体外去磷酸化前天冬氨酸酶-9对半胱氨酸天冬氨酸酶-9活性的影响
磷酸化调节前天冬氨酸酶-9的激活;(4)NO供体(二乙胺NOate)和
过氧亚硝酸根对SH-PTP-1和SH-PTP-2活性的影响
缺氧导致SH-PTP-1和SH-PTP-2失活,导致EGFR活性增加
蛋白酪氨酸酶原-9和蛋白天冬氨酸氨基转移酶-1的酪氨酸磷酸化水平
蛋白酪氨酸激酶依赖的机制。
建议的研究将建立一种新的机制,即NO介导的EGFR激酶和Src激酶依赖
Tyr153位的前天冬氨酸氨基转移酶-9和24位的APAF-1的酪氨酸磷酸化导致
激活前天冬氨酸氨基转移酶-9,导致缺氧性神经元死亡。一氧化氮介导的酪氨酸的研究进展
低氧时原天冬氨酸酶-9激活依赖于磷酸化的分子机制将有助于
基于酪氨酸激酶抑制的低氧脑损伤预防策略的研究进展
新生儿的功能障碍。
英文摘要
The proposed studies will investigate nitric oxide (NO)-mediated mechanism of procaspase-9 activation that
results in hypoxic neuronal death by transcription-independent and transcription-dependent pathways in the
newborn. We will test the hypothesis that NO produced during hypoxia leads to increased phosphorylation at
tyrosine 153 (Tyr153) of procaspase-9 and increased phosphorylation at tyrosine 24 (Tyr24) of apoptotic
protease activating factor-1 (Apaf-1) resulting in tyrosine phosphorylation-dependent activation of
procaspase-9.. We propose that tyrosine phosphorylation at specific residues during hypoxia leads to
increased binding of procaspase-9 with Apaf-1 due to increased charge-charge interaction (increased
number of H-bonds) between their prodomains and results in increased activation of procaspase-9. We
propose that NO free radicals generated during hypoxia lead to inactivation of protein tyrosine phosphatases
(PTP, SH-PTP-1 and SH-PTP-2) and result in increased activation of protein tyrosine kinases (PTK, EGFR
kinase and Src kinase) and subsequently increased tyrosine phosphorylation of procaspase-9 and Apaf-1.
The degree of cerebral tissue hypoxia will be determined by measurement of high energy phosphate
compounds. Experimental protocols will be carried out on newborn piglets investigating: (1) the effect of
hypoxia on Tyr153 phosphorylation of procaspase-9 and Tyr24 phosphorylation of Apaf-1, expression and
activation of procaspase-9 and relate these to the degree of cerebral hypoxia; and perform these studies
with the administration of highly selective nNOS inhibitors to demonstrate that the hypoxia-induced increased
Tyr153 phosphorylation of procaspase-9, Tyr24 phosphorylation of Apaf-1, expression and increased activation
of procaspase-9 are mediated by nNOS-derived NO; (2) the effect of inhibitors of EGFR kinase and Src
kinase on increased phosphorylation of procaspase-9 at Tyr153 and Apaf-1 at Tyr24, activation of procaspase-
9 and procaspase-3, nuclear DNA fragmentation and immunocytochemical and morphological indices of
neuronal death, to demonstrate that the mechanism of procaspase-9 activation that results in hypoxic
neuronal death is dependent on EGFR and Src kinase activity; (3) the effect of tyrosine phosphorylation and
dephosphorylation of procaspase-9 in vitro on caspase-9 activity to demonstrate that tyrosine
phosphorylation regulates procaspase-9 activation; (4) the effect of NO donor (diethylamine NONOate) and
peroxynitrite on the activity of SH-PTP-1 and SH-PTP-2 to demonstrate that NO-free radicals generated
during hypoxia lead to inactivation of SH-PTP-1 and SH-PTP-2 resulting in increased activation of EGFR
kinase and Src kinase and subsequently increased tyrosine phosphorylation of procaspase-9 and Apaf-1 by
a protein tyrosine kinase-dependent mechanism.
The proposed studies will establish a novel mechanism of NO-mediated EGFR kinase and Src kinasedependent
tyrosine phosphorylation of procaspase-9 at Tyr153 and Apaf-1 at Tyr24 leading to increased
activation of procaspase-9 that results in hypoxic neuronal death. The elucidation of NO-mediated tyrosine
phosphorylation-dependent molecular mechanism of procaspase-9 activation during hypoxia will aid in the
development of novel tyrosine-kinase inhibition based preventive strategies for hypoxia-induced brain
dysfunction in the newborn.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NO MEDIATED MODIFICATION OF NMDA RECEPTOR DURING HYPOXIA
-
批准号:6388160
-
项目类别:
-
资助金额:$24.6万
-
财政年份:1999
-
负责人:OM P MISHRA
-
依托单位:
NO-MEDIATED MODIFICATION OF NMDA RECEPTOR DURING HYPOXIA
-
批准号:6544826
-
项目类别:
-
资助金额:$33.98万
-
财政年份:1999
-
负责人:OM P MISHRA
-
依托单位:
NO MEDIATED MODIFICATION OF NMDA RECEPTOR DURING HYPOXIA
-
批准号:2898381
-
项目类别:
-
资助金额:$23.5万
-
财政年份:1999
-
负责人:OM P MISHRA
-
依托单位:
NO-MEDIATED MODIFICATION OF NMDA RECEPTOR DURING HYPOXIA
-
批准号:6862753
-
项目类别:
-
资助金额:$33.98万
-
财政年份:1999
-
负责人:OM P MISHRA
-
依托单位:
NO MEDIATED MODIFICATION OF NMDA RECEPTOR DURING HYPOXIA
-
批准号:6182595
-
项目类别:
-
资助金额:$24.04万
-
财政年份:1999
-
负责人:OM P MISHRA
-
依托单位:
NO-MEDIATED MODIFICATION OF NMDA RECEPTOR DURING HYPOXIA
-
批准号:6640311
-
项目类别:
-
资助金额:$33.98万
-
财政年份:1999
-
负责人:OM P MISHRA
-
依托单位:
NO-MEDIATED MODIFICATION OF NMDA RECEPTOR DURING HYPOXIA
-
批准号:6726867
-
项目类别:
-
资助金额:$33.98万
-
财政年份:1999
-
负责人:OM P MISHRA
-
依托单位:
NO-MEDIATED MODIFICATION OF NMDA RECEPTOR DURING HYPOXIA
-
批准号:7050231
-
项目类别:
-
资助金额:$33.18万
-
财政年份:1999
-
负责人:OM P MISHRA
-
依托单位:
海外基金